Natixis’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,827
| Closed | -$17.5K | – | 1008 |
|
|
2024
Q4 | $17.5K | Hold |
1,827
| – | – | ﹤0.01% | 926 |
|
|
2024
Q3 | $15.3K | Hold |
1,827
| – | – | ﹤0.01% | 825 |
|
|
2024
Q2 | $12.5K | Sell |
1,827
-11,273
| -86% | -$76.9K | ﹤0.01% | 819 |
|
|
2024
Q1 | $33.1K | Sell |
13,100
-27,715
| -68% | -$70.1K | ﹤0.01% | 832 |
|
|
2023
Q4 | $98K | Sell |
40,815
-253,712
| -86% | -$609K | ﹤0.01% | 756 |
|
|
2023
Q3 | $1M | Buy |
294,527
+292,700
| +16,021% | +$995K | 0.01% | 486 |
|
|
2023
Q2 | $13.4K | Sell |
1,827
-464
| -20% | -$3.41K | ﹤0.01% | 908 |
|
|
2023
Q1 | $23.7K | Buy |
+2,291
| New | +$23.7K | ﹤0.01% | 849 |
|
|
2022
Q2 | – | Sell |
-7,194
| Closed | -$295K | – | 1104 |
|
|
2022
Q1 | $295K | Sell |
7,194
-318
| -4% | -$13K | ﹤0.01% | 1066 |
|
|
2021
Q4 | $327K | Sell |
7,512
-25,950
| -78% | -$1.13M | ﹤0.01% | 1118 |
|
|
2021
Q3 | $1.68M | Buy |
33,462
+23,109
| +223% | +$1.16M | 0.01% | 764 |
|
|
2021
Q2 | $652K | Sell |
10,353
-670
| -6% | -$42.2K | ﹤0.01% | 669 |
|
|
2021
Q1 | $1.02M | Buy |
11,023
+278
| +3% | +$25.8K | ﹤0.01% | 828 |
|
|
2020
Q4 | $963K | Buy |
+10,745
| New | +$963K | ﹤0.01% | 808 |
|
|
2017
Q4 | – | Sell |
-5,018
| Closed | -$203K | – | 919 |
|
|
2017
Q3 | $203K | Buy |
+5,018
| New | +$203K | ﹤0.01% | 1123 |
|
|
2016
Q2 | – | Sell |
-5,651
| Closed | -$205K | – | 412 |
|
|
2016
Q1 | $205K | Buy |
+5,651
| New | +$205K | ﹤0.01% | 284 |
|